Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma

Barbara Marengo(University of Genoa), Cinzia Domenicotti(University of Genoa)
Oncotarget
September 15, 2020
Cited by 10


Related Papers